Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Women well-informed about breast cancer although lack knowledge about current treatments

Women well-informed about breast cancer although lack knowledge about current treatments

Study finds lymphoma drug effective over long term

Study finds lymphoma drug effective over long term

Study shows combination improves survival of metastatic melanoma patients

Study shows combination improves survival of metastatic melanoma patients

Benefits of Herceptin are lasting

Benefits of Herceptin are lasting

Adding radioimmunotherapy to chemo may help patients with lymphoma

Adding radioimmunotherapy to chemo may help patients with lymphoma

Study tests oral insulin to prevent type 1 diabetes

Study tests oral insulin to prevent type 1 diabetes

Human antibodies protect mice from H5N1 avian influenza

Human antibodies protect mice from H5N1 avian influenza

H5N1 influenza virus survivors' antibodies effective at neutralising H5N1 strain

H5N1 influenza virus survivors' antibodies effective at neutralising H5N1 strain

Peregrine Pharmaceuticals to initiate new Bavituximab HCV trial

Peregrine Pharmaceuticals to initiate new Bavituximab HCV trial

Complement receptor 3 sends a signal to dampen the immune system

Complement receptor 3 sends a signal to dampen the immune system

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Magnesium loss In patients given monoclonal antibodies

Magnesium loss In patients given monoclonal antibodies

Adalimumab shows potential for Crohn's disease

Adalimumab shows potential for Crohn's disease

Cancer Research Technology licenses therapeutic antibodies to Peptech

Cancer Research Technology licenses therapeutic antibodies to Peptech

PDL BioPharma's European patent claims upheld

PDL BioPharma's European patent claims upheld

New research may help identify patients most likely to benefit from cisplatin treatment

New research may help identify patients most likely to benefit from cisplatin treatment

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Immunomedics presents results on novel immunotoxin for prostate and lung cancers

Immunomedics presents results on novel immunotoxin for prostate and lung cancers

Peregrine's selective anti-VEGF antibodies shown to be as effective as Avastin

Peregrine's selective anti-VEGF antibodies shown to be as effective as Avastin

Abbott opens biotech facility in Puerto Rico

Abbott opens biotech facility in Puerto Rico

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.